EUVIMEDAtrasti EUVIMED
Crossref

Safety and Efficacy of Selective Plasma Exchange Versus Conventional Plasma Exchange in Pretransplant Desensitization of ABO ‐Incompatible Kidney Transplantation

Takahiro Inoue iD, Hajime Hirano iD, Yu Munakata, Yuki Kawaguchi iD, Ken Tsuchiya, Kohei Unagami iD, Junichi Hoshino iD, Hideki Ishida iD, Toshio Takagi, Norio Hanafusa iD

Journal of Clinical Apheresis · 2026

DOI: 10.1002/jca.70186 ↗

At a glance

Journal article in Journal of Clinical Apheresis, 2026. Written by Takahiro Inoue and 9 co-authors. Institution: Department of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan. Major MEDLINE topics: Plasma Exchange, Kidney Transplantation, ABO Blood-Group System, Blood Group Incompatibility. 18 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Selective plasma exchange (SePE) may reduce adverse events associated with fresh frozen plasma (FFP) use during pretransplant desensitization for ABO‐incompatible kidney transplantation. We conducted a single‐center retrospective cohort study of 75 patients who underwent ABO‐incompatible kidney transplantation between January 2020 and April 2024. Of these, 48 received SePE and 27 received conventional plasma exchange (CPE) with FFP. We compared antibody titers at transplantation, perioperative outcomes, and procedure‐related adverse events between the groups. Adverse events occurred in 5 patients (10.4%) in the SePE group and 17 patients (63.0%) in the CPE group ( p < 0.001). Anaphylactic shock occurred in no patients in the SePE group and 4 patients (14.8%) in the CPE group ( p = 0.027). All patients in the SePE group and all but one patient in the CPE group achieved the prespecified preoperative antibody titer target of ≤ 1:32. Neither surgical operating time nor intraoperative blood loss differed significantly between the groups. In this cohort, SePE was associated with fewer procedure‐related adverse events than CPE with FFP while achieving the preoperative antibody titer target in all SePE‐treated patients.

Subjects

MeSH terms (MEDLINE)

Plasma ExchangeKidney TransplantationABO Blood-Group SystemBlood Group IncompatibilityDesensitization, ImmunologicHumansFemaleRetrospective StudiesMaleMiddle AgedAdult

Author keywords

ABO‐incompatiblekidneyselective plasma exchangetransplantation

Substances

ABO Blood-Group System

Authors and institutions

  • Department of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.

ORCID profiles: Takahiro Inoue, Hajime Hirano, Yuki Kawaguchi, Kohei Unagami, Junichi Hoshino, Hideki Ishida, Norio Hanafusa

Cite

APA

Inoue, T., Hirano, H., Munakata, Y., Kawaguchi, Y., Tsuchiya, K., Unagami, K., Hoshino, J., Ishida, H., Takagi, T., & Hanafusa, N. (2026). Safety and Efficacy of Selective Plasma Exchange Versus Conventional Plasma Exchange in Pretransplant Desensitization of ABO ‐Incompatible Kidney Transplantation. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70186

Vancouver

Inoue T, Hirano H, Munakata Y, Kawaguchi Y, Tsuchiya K, Unagami K, et al. Safety and Efficacy of Selective Plasma Exchange Versus Conventional Plasma Exchange in Pretransplant Desensitization of ABO ‐Incompatible Kidney Transplantation. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70186

BibTeX
@article{Inoue2026,
  author = {Inoue, Takahiro and Hirano, Hajime and Munakata, Yu and Kawaguchi, Yuki and Tsuchiya, Ken and Unagami, Kohei and Hoshino, Junichi and Ishida, Hideki and Takagi, Toshio and Hanafusa, Norio},
  title = {Safety and Efficacy of Selective Plasma Exchange Versus Conventional Plasma Exchange in Pretransplant Desensitization of ABO ‐Incompatible Kidney Transplantation},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  doi = {10.1002/jca.70186}
}
Start for free →